UPDATED Apr 28, 2024
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
ARS | RON9.24 | -0.6% | 24.9% | RON1.4b | n/a | PE15.1x | n/a | 2.3% | ||
BKS | RON5.65 | -15.7% | n/a | RON905.3m | n/a | PE23.4x | n/a | n/a | ||
CBC | RON160.00 | 3.9% | 384.8% | RON788.1m | n/a | PE6.5x | n/a | 0% | ||
IARV | RON14.00 | 0.7% | 37.9% | RON255.9m | n/a | PE10.6x | n/a | 2.1% | ||
SNC | RON3.80 | -2.1% | n/a | RON247.0m | n/a | PE6.5x | n/a | n/a | ||
ARTE | RON17.40 | -10.3% | 32.8% | RON141.2m | n/a | PE16.1x | n/a | 3.1% | ||
CMF | RON5.85 | 5.4% | 154.3% | RON131.5m | n/a | PE14.1x | n/a | 3.1% | ||
IPRU | RON0.94 | -1.0% | n/a | RON118.4m | n/a | PE8.4x | n/a | 0% | ||
TBM | RON0.31 | 0% | 29.2% | RON116.0m | n/a | PE10.8x | n/a | 7.8% | ||
CONQ | RON8.60 | 0% | n/a | RON114.3m | n/a | PE3049.7x | n/a | n/a | ||
RORX | RON16.00 | 0% | n/a | RON111.2m | n/a | PS1.9x | n/a | n/a | ||
SPX | RON0.35 | -1.1% | n/a | RON92.2m | n/a | n/a | n/a | n/a | ||
INTA | RON31.80 | 38.3% | n/a | RON91.3m | n/a | PE44.9x | n/a | n/a | ||
IAMU | RON9.00 | 0% | n/a | RON85.5m | n/a | PE10.6x | n/a | n/a | ||
COKJ | RON74.50 | 0% | n/a | RON76.1m | n/a | PE2.3x | n/a | n/a | ||
SNO | RON6.60 | 0% | 38.1% | RON75.4m | n/a | PE21.8x | n/a | 8.0% | ||
CAIN | RON50.00 | 5.9% | n/a | RON73.3m | n/a | PE35.8x | n/a | 2.1% | ||
AVIO | RON2.08 | 4.0% | n/a | RON66.8m | n/a | n/a | n/a | n/a | ||
FACY | RON10.50 | 0% | n/a | RON59.3m | n/a | PE42.5x | n/a | 0% | ||
REFE | RON28.00 | -9.7% | n/a | RON57.3m | n/a | PS1.2x | n/a | n/a | ||
COTM | RON5.10 | 0% | n/a | RON55.5m | n/a | PE241x | n/a | n/a | ||
SELC | RON0.90 | 0% | n/a | RON40.1m | n/a | PE7x | n/a | n/a | ||
MCAB | RON0.039 | 6.6% | -70.4% | RON39.4m | n/a | PE2.4x | n/a | n/a | ||
AAG | RON3.90 | -1.0% | 1.0% | RON39.0m | n/a | PE5.8x | n/a | 8.2% |